Citations (121)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Tamer Rezk, Marianna Fontana & Julian D. Gillmore. (2021) A review of the criteria for non-invasive diagnosis of cardiac transthyretin amyloidosis. Expert Opinion on Orphan Drugs 9:3, pages 87-94.
Read now
Read now
Hassan Alkhawam, Darshan Patel, James Nguyen, Saumya Mariam Easaw, Mohammed Al-Sadawi, Umer Syed, Feras Zaiem, Maher Homsi & Timothy J. Vittorio. (2017) Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options. Acta Cardiologica 72:4, pages 380-389.
Read now
Read now
Björn Pilebro, Ole B. Suhr, Ulf Näslund, Per Westermark, Per Lindqvist & Torbjörn Sundström. (2016) 99mTc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis. Upsala Journal of Medical Sciences 121:1, pages 17-24.
Read now
Read now
Arnault Galat, Jean Rosso, Aziz Guellich, Axel Van Der Gucht, Stephane Rappeneau, Diane Bodez, Soulef Guendouz, Claire-Marie Tissot, Luc Hittinger, Jean-Luc Dubois-Randé, Violaine Plante-Bordeneuve, Emmanuel Itti, Michel Meignan & Thibaud Damy. (2015) Usefulness of 99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis. Amyloid 22:4, pages 210-220.
Read now
Read now
Taxiarchis V Kourelis & Morie A Gertz. (2015) Improving strategies for the diagnosis of cardiac amyloidosis. Expert Review of Cardiovascular Therapy 13:8, pages 945-961.
Read now
Read now
Articles from other publishers (116)
Dulce Brito, Fabiano Castro Albrecht, Diego Perez de Arenaza, Nicole Bart, Nathan Better, Isabel Carvajal-Juarez, Isabel Conceição, Thibaud Damy, Sharmila Dorbala, Jean-Christophe Fidalgo, Pablo Garcia-Pavia, Junbo Ge, Julian D. Gillmore, Jacek Grzybowski, Laura Obici, Daniel Piñero, Claudio Rapezzi, Mitsuharu Ueda & Fausto J. Pinto. (2023) World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM). Global Heart 18:1.
Crossref
Crossref
Aaisha Ferkh, Catherina Tjahjadi, Luke Stefani, Paul Geenty, Karen Byth, Kasun De Silva, Anita C. Boyd, David Richards, Peter Mollee, Dariusz Korczyk, Mark S. Taylor, Fiona Kwok, Eddy Kizana, Arnold C. T. Ng & Liza Thomas. (2023) Cardiac “hypertrophy” phenotyping: differentiating aetiologies with increased left ventricular wall thickness on echocardiography. Frontiers in Cardiovascular Medicine 10.
Crossref
Crossref
Talal Asif, Aviral Vij, Bartlomiej Radzik, Hudson Stern, Patricia Simples, Quraish Ghadiali & Saurabh Malhotra. (2021) Multimodality imaging for diagnosis of subclinical hereditary transthyretin cardiac amyloidosis. Journal of Nuclear Cardiology 30:2, pages 792-799.
Crossref
Crossref
Angelica Cersosimo, Andrea Bonelli, Carlo M. Lombardi, Antonella Moreo, Matteo Pagnesi, Daniela Tomasoni, Gianmarco Arabia, Enrico Vizzardi, Marianna Adamo, Davide Farina, Marco Metra & Riccardo M. Inciardi. (2023) Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis. Frontiers in Cardiovascular Medicine 10.
Crossref
Crossref
Yiu Ming Khor, Sarah A. M. Cuddy, Vasvi Singh, Rodney H. Falk, Marcelo F. Di Carli & Sharmila Dorbala. (2023)
99m
Tc Bone-Avid Tracer Cardiac Scintigraphy: Role in Noninvasive Diagnosis of Transthyretin Cardiac Amyloidosis
. Radiology 306:2.
Crossref
Crossref
Tim Wollenweber, Elisabeth Kretschmer-Chott, Raphael Wurm, Sazan Rasul, Oana Kulterer, Rene Rettl, Franz Duca, Diana Bonderman, Kurt-Wolfram Sühs, Marcus Hacker & Tatjana Traub-Weidinger. (2022) Does [99mTc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) soft tissue uptake allow the identification of patients with the diagnosis of cardiac transthyretin-related (ATTR) amyloidosis with higher risk for polyneuropathy?. Journal of Nuclear Cardiology 30:1, pages 357-367.
Crossref
Crossref
Lukas Kessler, Pedro Fragoso Costa, David Kersting, Walter Jentzen, Manuel Weber, Peter Lüdike, Alexander Carpinteiro, Sara Oubari, Tim Hagenacker, Andreas Thimm, Tienush Rassaf, Ken Herrmann, Maria Papathanasiou & Christoph Rischpler. (2022) Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis. Journal of Nuclear Cardiology 30:1, pages 101-111.
Crossref
Crossref
Teodor Marian Ionescu, Manuela Ciocoiu, Raoul-Vasile Lupușoru, Irena Grierosu, Radu Andy Sascău, Wael Jalloul, Roxana Iacob, Cati Raluca Stolniceanu, Alexandra Clement, Ana-Maria Stătescu, Daniela Crișu, Antoniu Octavian Petriș, Florin Mitu & Cipriana Ștefănescu. (2022) Role of Diphosphonates Bone Scintigraphy in Correlation with Biomarkers for a Personalized Approach to ATTR Cardiac Amyloidosis in North-Eastern Romania. Diagnostics 13:1, pages 83.
Crossref
Crossref
Hanna-Leena Halme, Toni Ihalainen, Olli Suomalainen, Antti Loimaala, Sorjo Mätzke, Valtteri Uusitalo, Outi Sipilä & Eero Hippeläinen. (2022) Convolutional neural networks for detection of transthyretin amyloidosis in 2D scintigraphy images. EJNMMI Research 12:1.
Crossref
Crossref
Dia A. Smiley, Carlos M. Rodriguez & Mathew S. Maurer. (2022) Transthyretin Cardiac Amyloidosis. Cardiology Clinics 40:4, pages 541-558.
Crossref
Crossref
Golnaz Roshankar, Geneva C. White, Sebastien Cadet, Nowell M. Fine, Denise Chan, James A. White, Victor Jimenez-Zepeda, Piotr J. Slomka & Robert J. H. Miller. (2021) Quantitative technetium pyrophosphate and cardiovascular magnetic resonance in patients with suspected cardiac amyloidosis. Journal of Nuclear Cardiology 29:5, pages 2679-2690.
Crossref
Crossref
Mehmet Harapoz, Scott Evans, Paul Geenty, Fiona Kwok, Graeme Stewart, Mark S. Taylor, David Farlow & Liza Thomas. (2022) Correlation of Quantitative 99mTc DPD Scintigraphy With Echocardiographic Alterations in Left Atrial Parameters in Transthyretin Amyloidosis. Heart, Lung and Circulation 31:6, pages 804-814.
Crossref
Crossref
Olli Suomalainen, Jaagup Pilv, Antti Loimaala, Sorjo Mätzke, Tiina Heliö & Valtteri Uusitalo. (2020) Prognostic significance of incidental suspected transthyretin amyloidosis on routine bone scintigraphy. Journal of Nuclear Cardiology 29:3, pages 1021-1029.
Crossref
Crossref
Katrine Bay, Finn Gustafsson, Michael Maiborg, Anne Bagger‐Bahnsen, Anne Mette Strand, Trine Pilgaard & Steen Hvitfeldt Poulsen. (2022) Suspicion, screening, and diagnosis of wild‐type transthyretin amyloid cardiomyopathy: a systematic literature review. ESC Heart Failure 9:3, pages 1524-1541.
Crossref
Crossref
Valtteri Uusitalo, Olli Suomalainen, Antti Loimaala, Sorjo Mätzke & Tiina Heliö. (2022) Prognostic Value of 99mTc-HMDP Scintigraphy in Elderly Patients With Chronic Heart Failure. Heart, Lung and Circulation 31:5, pages 629-637.
Crossref
Crossref
Dimitri Bellevre, Alban Bailliez, François Delelis, Tanguy Blaire, Denis Agostini, Frédéric Mouquet, Sylvestre Maréchaux & Alain Manrique. (2020) Quantitation of myocardial 99mTc-HMDP uptake with new SPECT/CT cadmium zinc telluride (CZT) camera in patients with transthyretin-related cardiac amyloidosis: Ready for clinical use?. Journal of Nuclear Cardiology 29:2, pages 506-514.
Crossref
Crossref
Priyanka T. Bhattacharya, Mathew S. Maurer & Dia A. Smiley. (2022) Amyloid Cardiomyopathy in Older Adults. Current Geriatrics Reports 11:1, pages 1-9.
Crossref
Crossref
Giuseppe Palmiero, Erica Vetrano, Marta Rubino, Emanuele Monda, Francesca Dongiglio, Michele Lioncino, Francesco Di Fraia, Martina Caiazza, Federica Verrillo, Laura Capodicasa, Giuseppe Cerciello, Fiore Manganelli, Mara Catalano, Davide D'Arienzo, Maria Luisa De Rimini, Raffaele Ascione, Paolo Golino, Pio Caso, Luigi Ascione & Giuseppe Limongelli. (2022) The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis. Heart Failure Clinics 18:1, pages 61-72.
Crossref
Crossref
Michele Lioncino, Emanuele Monda, Giuseppe Palmiero, Martina Caiazza, Erica Vetrano, Marta Rubino, Augusto Esposito, Gemma Salerno, Francesca Dongiglio, Barbara D’Onofrio, Federica Verrillo, Giuseppe Cerciello, Fiore Manganelli, Giuseppe Pacileo, Eduardo Bossone, Paolo Golino, Paolo Calabrò & Giuseppe Limongelli. (2022) Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis. Heart Failure Clinics 18:1, pages 73-87.
Crossref
Crossref
Federico Caobelli & Cristina E. Popescu. 2022. Nuclear Medicine and Molecular Imaging. Nuclear Medicine and Molecular Imaging
171
178
.
Simona Ben-Haim, A. Chicheportiche, E. Goshen, M. Arad, M. Smekhov, L. J. Menezes, P. M. Elliott, E. O’Mahoney, E. Stern, Bella Yuzefovich & J. B. Bomanji. (2021) Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis. EJNMMI Research 11:1.
Crossref
Crossref
Jan Stassen, Pieter van der Bijl & Jeroen J. Bax. (2021) Optimizing 99mTc-DPD scintigraphy: Adding value to the diagnosis and treatment of cardiac transthyretin amyloidosis. Journal of Nuclear Cardiology 28:6, pages 2497-2499.
Crossref
Crossref
Imke Schatka, Anne Bingel, Franziska Schau, Stephanie Bluemel, Daniel R. Messroghli, David Frumkin, Fabian Knebel, Sonja M. Diekmann, Ahmed Elsanhoury, Carsten Tschöpe, Katrin Hahn, Holger Amthauer, Julian M. M. Rogasch & Christoph Wetz. (2021) An optimized imaging protocol for [99mTc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis. Journal of Nuclear Cardiology 28:6, pages 2483-2496.
Crossref
Crossref
Claire Cuscaden, Stuart C. Ramsay, Sandhir Prasad, Bruce Goodwin & Jye Smith. (2020) Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation. Journal of Nuclear Cardiology 28:6, pages 2845-2856.
Crossref
Crossref
Csilla Andrea Eötvös, Giorgia Pastiu, Iulia Zehan, Cerasela Goidescu, Roxana Chiorescu, Roxana Lazar, Florina Frîngu, Raluca Tomoaia, Monica Pop, Adrian Molnar, Sorin Pop & Dan Blendea. 2021. Cardiomyopathy - Disease of the Heart Muscle. Cardiomyopathy - Disease of the Heart Muscle.
Mehmet Harapoz, Scott Evans, Paul Geenty, Fiona Kwok, Graeme Stewart, Mark S. Taylor, David Farlow & Liza Thomas. (2021) Correlation Between Quantitative Uptake of 99mTC-DPD and Echocardiographic Parameters in Cardiac ATTR: A Novel Follow-Up Strategy. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Robert J. H. Miller, Sebastien Cadet, Darren Mah, Payam Pournazari, Denise Chan, Nowell M. Fine, Daniel S. Berman & Piotr J. Slomka. (2021) Diagnostic and prognostic value of Technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis. Journal of Nuclear Cardiology 28:5, pages 1835-1845.
Crossref
Crossref
Sang-Geon Cho, Hyung Yoon Kim & Hee-Seung Bom. (2019) What is the optimal cardiac screening for asymptomatic transthyretin gene mutation carriers?. Journal of Nuclear Cardiology 28:5, pages 1958-1960.
Crossref
Crossref
F. Minutoli, G. Di Bella, A. Mazzeo, R. Laudicella, L. Gentile, M. Russo, G. Vita & S. Baldari. (2019) Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation. Journal of Nuclear Cardiology 28:5, pages 1949-1957.
Crossref
Crossref
Temidayo Abe, Titilope Olanipekun, Mtanis Khoury, Obiora EgbucheValery EffoeJalal Ghali. (2021) Trends, Associations, and Impact of Atrial Fibrillation in Patients With Light-chain Cardiac Amyloidosis. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 20:3, pages 168-172.
Crossref
Crossref
Teodor M. Ionescu, Wael Jalloul, Cati R. Stolniceanu, Roxana Iacob, Laura P. Grecu, Ana-Maria Stătescu, Irena Grierosu, Mihai Guțu, Adrian Gavrilescu, Crișu Daniela, Antoniu Petriș, Manuela Ciocoiu, Cristina Ungureanu & Cipriana Ștefănescu. (2021) Transthyretin cardiac amyloidosis: a review of the nuclear imaging findings with emphasis on the radiotracers mechanisms. Annals of Nuclear Medicine 35:9, pages 967-993.
Crossref
Crossref
Sharmila DorbalaYukio AndoSabahat BokhariAngela DispenzieriRodney H. FalkVictor A. FerrariMarianna FontanaOlivier GheysensJulian D. GillmoreAndor W. J. M. GlaudemansMazen A. HannaBouke P. C. HazenbergArnt V. KristenRaymond Y. KwongMathew S. MaurerGiampaolo MerliniEdward J. MillerJames C. MoonVenkatesh L. MurthyC. Cristina QuartaClaudio RapezziFrederick L. RubergSanjiv J. ShahRiemer H. J. A. SlartHein J. VerberneJamieson M. Bourque. (2021) ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging. Circulation: Cardiovascular Imaging 14:7.
Crossref
Crossref
Francis T Delaney, Philip Dempsey, Ivan Welaratne, Bryan Buckley, Donagh O'Sullivan & Martin O'Connell. (2021) Incidental cardiac uptake in bone scintigraphy: increased importance and association with cardiac amyloidosis. BJR|case reports 7:3, pages 20200161.
Crossref
Crossref
Jin Chul Paeng & Joon Young Choi. (2021) Nuclear Imaging for Cardiac Amyloidosis: Bone Scan, SPECT/CT, and Amyloid-Targeting PET. Nuclear Medicine and Molecular Imaging 55:2, pages 61-70.
Crossref
Crossref
A. Yilmaz, J. Bauersachs, F. Bengel, R. Büchel, I. Kindermann, K. Klingel, F. Knebel, B. Meder, C. Morbach, E. Nagel, E. Schulze-Bahr, F. aus dem Siepen & N. Frey. (2021) Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK). Clinical Research in Cardiology 110:4, pages 479-506.
Crossref
Crossref
Gary R. Small & Terrence D. Ruddy. (2019) Straightening out the wrinkles in technetium-99m-labeled bone scintigraphy tracer assessment of cardiac amyloidosis. Journal of Nuclear Cardiology 28:1, pages 100-103.
Crossref
Crossref
Chiara Gallini, Francesca Tutino, Raffaele Martone, Alfonso Ciaccio, Egidio Natalino Costanzo, Giulia Taborchi, Sofia Morini, Simone Bartolini, Silvia Farsetti, Carlo Di Mario, Federico Perfetto & Francesco Cappelli. (2019) Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy. Journal of Nuclear Cardiology 28:1, pages 90-99.
Crossref
Crossref
Philip Haaf, Irene A. Burger, Michael J. Zellweger, Pankaj Garg & Cristina E. Popescu. 2021. Imaging of Inflammation and Infection in Cardiovascular Diseases. Imaging of Inflammation and Infection in Cardiovascular Diseases
37
69
.
Andreea Jercan, Amalia Ene, Ruxandra Jurcut, Mirela Draghici, Sorina Badelita, Mihaela Dragomir, Camelia Dobrea, Monica Popescu, Dumitru Jardan, Emanuel Stoica, Speranta Iacob, Ionela Codita, Claudiu Stan & Daniel Coriu. (2020) Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
M. Grandis, L. Obici, M. Luigetti, C. Briani, F. Benedicenti, G. Bisogni, M. Canepa, F. Cappelli, C. Danesino, G. M. Fabrizi, S. Fenu, G. Ferrandes, C. Gemelli, F. Manganelli, A. Mazzeo, L. Melchiorri, F. Perfetto, L. G. Pradotto, P. Rimessi, G. Tini, S. Tozza, L. Trevisan, D. Pareyson & P. Mandich. (2020) Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Gabriela Spencer-Bonilla, Kevin M. Alexander & Ronald M. Witteles. (2020) Advances in the Diagnosis and Management of Transthyretin Amyloid Cardiomyopathy. Current Treatment Options in Cardiovascular Medicine 22:11.
Crossref
Crossref
Viviana Frantellizzi, Laura Cosma, Arianna Pani, Mariano Pontico, Miriam Conte, Cristina De Angelis & Giuseppe De Vincentis. (2020) Role of Nuclear Imaging in Cardiac Amyloidosis Management: Clinical Evidence and Review of Literature. Current Medical Imaging Formerly Current Medical Imaging Reviews 16:8, pages 957-966.
Crossref
Crossref
Daphne L. Jonker, Bouke P. C. Hazenberg, Hans L. A. Nienhuis, Riemer H. J. A. Slart, Andor W. J. M. Glaudemans & Walter Noordzij. (2018) Imaging cardiac innervation in hereditary transthyretin (ATTRm) amyloidosis: A marker for neuropathy or cardiomyopathy in case of heart failure?. Journal of Nuclear Cardiology 27:5, pages 1774-1784.
Crossref
Crossref
Sebastiaan HC Klaassen, Dirk J van Veldhuisen, Hans LA Nienhuis, Maarten P van den Berg, Bouke PC Hazenberg & Peter van der Meer. (2020) Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?. Cardiac Failure Review 6.
Crossref
Crossref
Yiu Ming Khor, Sarah Cuddy, Rodney H. Falk & Sharmila Dorbala. (2020) Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis. Seminars in Nuclear Medicine 50:4, pages 295-310.
Crossref
Crossref
Ana Martinez-Naharro, A. John Baksi, Philip N. Hawkins & Marianna Fontana. (2020) Diagnostic imaging of cardiac amyloidosis. Nature Reviews Cardiology 17:7, pages 413-426.
Crossref
Crossref
Gian Luca Vita, M’Hammed Aguennouz, Francesca Polito, Rosaria Oteri, Massimo Russo, Luca Gentile, Cristina Barbagallo, Marco Ragusa, Carmelo Rodolico, Rosa Maria Di Giorgio, Antonio Toscano, Giuseppe Vita & Anna Mazzeo. (2020) Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis. Frontiers in Molecular Neuroscience 13.
Crossref
Crossref
Chrysanthos Grigoratos, Alberto Aimo, Claudio Rapezzi, Dario Genovesi, Andrea Barison, Giovanni Donato Aquaro, Giuseppe Vergaro, Angela Pucci, Claudio Passino, Paolo Marzullo, Alessia Gimelli & Michele Emdin. (2020) Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis. International Journal of Cardiology 307, pages 187-192.
Crossref
Crossref
Giedre Balciunaite, Arnas Rimkus, Edvardas Zurauskas, Tomas Zaremba, Darius Palionis, Nomeda Valeviciene, Audrius Aidietis, Pranas Serpytis, Kestutis Rucinskas, Peter Sogaard, Sigita Glaveckaite, Aleksejus Zorinas & Vilius Janusauskas. (2020) Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications. Hellenic Journal of Cardiology 61:2, pages 92-98.
Crossref
Crossref
Carmela Nappi, Roberta Assante, Emilia Zampella & Alberto Cuocolo. (2018) Cardiac amyloidosis: A new challenge of multimodality imaging. Journal of Nuclear Cardiology 27:1, pages 106-108.
Crossref
Crossref
Elissa Driggin & Mathew S. Maurer. (2019) The quintessential form of diastolic heart failure in older adults: Wild type transthyretin cardiac amyloidosis. Clinical Cardiology 43:2, pages 171-178.
Crossref
Crossref
Temidayo Abe, Eric Y Chang, Gabrielle De Allie, Taiwo Ajose, Chukwuemeka Nwokike & Nicolas Bakinde. (2020) Rapid decline in ejection fraction and persistent elevation of troponin associated with cardiac amyloidosis. SAGE Open Medical Case Reports 8, pages 2050313X2092325.
Crossref
Crossref
Joohee Lee, Kihyun KimJin-Oh ChoiSeok Jin KimEun-Seok JeonJoon Young Choi. (2020) 99mTc-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis. Medicine 99:4, pages e18905.
Crossref
Crossref
Alain Manrique, David Dudoignon, Stéphanie Brun, Catherine N’Ganoa, Emmanuelle Cassol, Damien Legallois, Yoan Lavie-Badie, Denis Agostini & Olivier Lairez. (2019) Quantification of myocardial 99mTc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis. EJNMMI Research 9:1.
Crossref
Crossref
Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, Angela Dispenzieri, Rodney H. Falk, Victor A. Ferrari, Marianna Fontana, Olivier Gheysens, Julian D. Gillmore, Andor W. J. M. Glaudemans, Mazen A. Hanna, Bouke P. C. Hazenberg, Arnt V. Kristen, Raymond Y. Kwong, Mathew S. Maurer, Giampaolo Merlini, Edward J. Miller, James C. Moon, Venkatesh L. Murthy, C. Cristina Quarta, Claudio Rapezzi, Frederick L. Ruberg, Sanjiv J. Shah, Riemer H. J. A. Slart, Hein J. Verberne & Jamieson M. Bourque. (2019) ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging. Journal of Nuclear Cardiology 26:6, pages 2065-2123.
Crossref
Crossref
Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, Angela Dispenzieri, Rodney H. Falk, Victor A. Ferrari, Marianna Fontana, Olivier Gheysens, Julian D. Gillmore, Andor W.J.M. Glaudemans, Mazen A. Hanna, Bouke P.C. Hazenberg, Arnt V. Kristen, Raymond Y. Kwong, Mathew S. Maurer, Giampaolo Merlini, Edward J. Miller, James C. Moon, Venkatesh L. Murthy, C. Cristina Quarta, Claudio Rapezzi, Frederick L. Ruberg, Sanjiv J. Shah, Riemer H.J.A. Slart, Hein J. Verberne & Jamieson M. Bourque. (2019) ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging. Journal of Cardiac Failure 25:11, pages e1-e39.
Crossref
Crossref
Claudio Rapezzi, Christian Gagliardi & Agnese Milandri. (2018) Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis. Journal of Nuclear Cardiology 26:5, pages 1638-1641.
Crossref
Crossref
Mathew S. MaurerSabahat BokhariThibaud DamySharmila DorbalaBrian M. DrachmanMarianna FontanaMartha GroganArnt V. KristenIsabelle LousadaJose Nativi-NicolauCandida Cristina QuartaClaudio RapezziFrederick L. RubergRonald WittelesGiampaolo Merlini. (2019) Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. Circulation: Heart Failure 12:9.
Crossref
Crossref
Irina Iuliana Costache, Ana Maria Buburuz, Daniela Crisu, Ana Maria Statescu, Carmen UngureanuViviana Aursulesei. (2019) The role of echocardiography and 99mTc-HDP scintigraphy in non-invasive diagnosis of cardiac amyloidosis. Medicine 98:38, pages e17256.
Crossref
Crossref
Antonis S. Manolis, Antonis A. Manolis, Theodora A. Manolis & Helen Melita. (2019) Cardiac amyloidosis: An underdiagnosed/underappreciated disease. European Journal of Internal Medicine 67, pages 1-13.
Crossref
Crossref
A. Yilmaz, J. Bauersachs, I. Kindermann, K. Klingel, F. Knebel, B. Meder, C. Morbach, E. Nagel, E. Schulze-Bahr, F. aus dem Siepen & N. Frey. (2019) Diagnostik und Therapie der kardialen AmyloidoseDiagnostics and treatment of cardiac amyloidosis. Der Kardiologe 13:5, pages 264-291.
Crossref
Crossref
Angelos G. Rigopoulos, Muhammad Ali, Elena Abate, Abdel-Rahman Torky, Marios Matiakis, Mammad Mammadov, Hannes Melnyk, Alexander Vogt, Renato de Vecchis, Boris Bigalke, Walter Wohlgemuth, Sophie Mavrogeni & Michel Noutsias. (2019) Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement. Heart Failure Reviews 24:4, pages 521-533.
Crossref
Crossref
Riemer H. J. A. Slart, Andor W. J. M. Glaudemans, Walter Noordzij, Johan Bijzet, Bouke P. C. Hazenberg & Hans L. A. Nienhuis. (2019) Time for new imaging and therapeutic approaches in cardiac amyloidosis. European Journal of Nuclear Medicine and Molecular Imaging 46:7, pages 1402-1406.
Crossref
Crossref
Diana Michels da Silva, Harald Langer & Tobias Graf. (2019) Inflammatory and Molecular Pathways in Heart Failure—Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis. International Journal of Molecular Sciences 20:9, pages 2322.
Crossref
Crossref
Ana Martinez-Naharro, Tushar Kotecha, Karl Norrington, Michele Boldrini, Tamer Rezk, Candida Quarta, Thomas A. Treibel, Carol J. Whelan, Daniel S. Knight, Peter Kellman, Frederick L. Ruberg, Julian D. Gillmore, James C. Moon, Philip N. Hawkins & Marianna Fontana. (2019) Native T1 and Extracellular Volume in Transthyretin Amyloidosis. JACC: Cardiovascular Imaging 12:5, pages 810-819.
Crossref
Crossref
Maarten P van den Berg, Bart A Mulder, Sebastiaan H C Klaassen, Alexander H Maass, Dirk J van Veldhuisen, Peter van der Meer, Hans L A Nienhuis, Bouke P C Hazenberg & Michiel Rienstra. (2019) Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis. European Heart Journal 40:16, pages 1287-1293.
Crossref
Crossref
Efstathia Andrikopoulou & Pradeep Bhambhvani. (2017) Nuclear imaging of cardiac amyloidosis. Journal of Nuclear Cardiology 26:2, pages 505-508.
Crossref
Crossref
Francesco Cappelli, Chiara Gallini, Carlo Di Mario, Egidio Natalino Costanzo, Luca Vaggelli, Francesca Tutino, Alfonso Ciaccio, Simone Bartolini, Paola Angelotti, Sabrina Frusconi, Silvia Farsetti, Giuseppe Vergaro, Assuero Giorgetti, Paolo Marzullo, Dario Genovesi, Michele Emdin & Federico Perfetto. (2017) Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis. Journal of Nuclear Cardiology 26:2, pages 497-504.
Crossref
Crossref
Stuart C. Ramsay, Karen Lindsay, William Fong, Shaun Patford, John Younger & John Atherton. (2018) Tc-HDP quantitative SPECT/CT in transthyretin cardiac amyloid and the development of a reference interval for myocardial uptake in the non-affected population. European Journal of Hybrid Imaging 2:1.
Crossref
Crossref
Samia Massalha & Terrence D. Ruddy. (2017) Emerging role of echocardiography, cardiac magnetic resonance imaging and 99mTc-labeled bone tracer scintigraphy for the diagnosis of cardiac amyloidosis. Journal of Nuclear Cardiology 25:6, pages 2080-2083.
Crossref
Crossref
Axel Van Der Gucht, Anne-Ségolène Cottereau, Mukedaisi Abulizi, Aziz Guellich, Paul Blanc-Durand, Jean-Marc Israel, Arnault Galat, Violaine Plante-Bordeneuve, Jean-Luc Dubois-Randé, Diane Bodez, Jean Rosso, Thibaud Damy & Emmanuel Itti. (2017) Apical sparing pattern of left ventricular myocardial 99mTc-HMDP uptake in patients with transthyretin cardiac amyloidosis. Journal of Nuclear Cardiology 25:6, pages 2072-2079.
Crossref
Crossref
Laroussi Mohamed-Salem, Juan José Santos-Mateo, Juan Sanchez-Serna, Álvaro Hernández-Vicente, Rafael Reyes-Marle, María I. Castellón Sánchez, María Antonia Claver-Valderas, Emiliano Gonzalez-Vioque, Francisco J. Haro-del Moral, Pablo García-Pavía & Domingo A. Pascual-Figal. (2018) Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population. International Journal of Cardiology 270, pages 192-196.
Crossref
Crossref
Giorgio Treglia, Andor W. J. M. Glaudemans, Francesco Bertagna, Bouke P. C. Hazenberg, Paola A. Erba, Raffaele Giubbini, Luca Ceriani, John O. Prior, Luca Giovanella & Riemer H. J. A. Slart. (2018) Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging 45:11, pages 1945-1955.
Crossref
Crossref
Mathew S. MaurerJeffrey H. SchwartzBalarama GundapaneniPerry M. ElliottGiampaolo MerliniMarcia Waddington-CruzArnt V. KristenMartha GroganRonald WittelesThibaud DamyBrian M. DrachmanSanjiv J. ShahMazen HannaDaniel P. JudgeAlexandra I. BarsdorfPeter HuberTerrell A. PattersonSteven RileyJennifer SchumacherMichelle StewartMarla B. SultanClaudio Rapezzi. (2018) Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. New England Journal of Medicine 379:11, pages 1007-1016.
Crossref
Crossref
Julian D Gillmore, Thibaud Damy, Marianna Fontana, Matthew Hutchinson, Helen J Lachmann, Ana Martinez-Naharro, Candida C Quarta, Tamer Rezk, Carol J Whelan, Esther Gonzalez-Lopez, Thirusha Lane, Janet A Gilbertson, Dorota Rowczenio, Aviva Petrie & Philip N Hawkins. (2018) A new staging system for cardiac transthyretin amyloidosis. European Heart Journal 39:30, pages 2799-2806.
Crossref
Crossref
Michael N. Vranian, Brett W. Sperry, Mazen Hanna, Rory Hachamovitch, Asad Ikram, Richard C. Brunken & Wael A. Jaber. (2017) Technetium pyrophosphate uptake in transthyretin cardiac amyloidosis: Associations with echocardiographic disease severity and outcomes. Journal of Nuclear Cardiology 25:4, pages 1247-1256.
Crossref
Crossref
Eve Piekarski, Renata Chequer, Vincent Algalarrondo, Ludivine Eliahou, Besma Mahida, Jonathan Vigne, David Adams, Michel S. Slama, Dominique Le Guludec & Francois Rouzet. (2018) Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers. European Journal of Nuclear Medicine and Molecular Imaging 45:7, pages 1108-1118.
Crossref
Crossref
Wengen Chen, Van-Khue Ton & Vasken Dilsizian. (2018) Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction. Current Cardiology Reports 20:4.
Crossref
Crossref
Quinn K.T. NgPooja SethiTara A. SaundersMiguel Hernandez PampaloniRobert R. Flavell. (2018) Discordant Findings on 18F-NaF and 99mTc-HDP Bone Scans in a Patient With ATTR Cardiac Amyloidosis. Clinical Nuclear Medicine 43:3, pages e89-e92.
Crossref
Crossref
Francesco Cappelli, Chiara Gallini, Egidio Natalino Costanzo, Francesca Tutino, Alfonso Ciaccio, Luca Vaggelli, Simone Bartolini, Sofia Morini, Raffaele Martone, Paola Angelotti, Sabrina Frusconi, Carlo Di Mario & Federico Perfetto. (2018) Lung uptake during 99mTc- hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon. International Journal of Cardiology 254, pages 346-350.
Crossref
Crossref
Brett W. Sperry, Michael N. Vranian, Albree Tower-Rader, Rory Hachamovitch, Mazen Hanna, Richard Brunken, Dermot Phelan, Manuel D. Cerqueira & Wael A. Jaber. (2018) Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality. JACC: Cardiovascular Imaging 11:2, pages 234-242.
Crossref
Crossref
Mukedaisi Abulizi, Anne-Ségolène Cottereau, Aziz Guellich, Stéphanie Vandeventer, Arnault Galat, Axel Van Der Gucht, Violaine Plante-Bordeneuve, Jean-Luc Dubois-Randé, Diane Bodez, Jean Rosso, Thibaud Damy & Emmanuel Itti. (2016) Early-phase myocardial uptake intensity of 99mTc-HMDP vs 99mTc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis. Journal of Nuclear Cardiology 25:1, pages 217-222.
Crossref
Crossref
Gilbert Habib, Chiara Bucciarelli-Ducci, Alida L. P. Caforio, Nuno Cardim, Philippe Charron, Bernard Cosyns, Aurélie Dehaene, Genevieve Derumeaux, Erwan Donal, Marc R. Dweck, Thor Edvardsen, Paola Anna Erba, Laura Ernande, Oliver Gaemperli, Maurizio Galderisi, Julia Grapsa, Alexis Jacquier, Karin Klingel, Patrizio Lancellotti, Danilo Neglia, Alessia Pepe, Pasquale Perrone-Filardi, Steffen E. Petersen, Sven Plein, Bogdan A. Popescu, Patricia Reant, L. Elit Sade, Erwan Salaun, Riemer H.J.A. Slart, Christophe Tribouilloy & Jose Zamorano. (2018) Multimodality Imaging in Restrictive Cardiomyopathies: An European Association of Cardiovascular Imaging Expert Consensus Document in Collaboration with the “Working Group on Myocardial and Pericardial Diseases” of the European Society of Cardiology Endorsed by the Indian Academy of Echocardiography. Journal of The Indian Academy of Echocardiography & Cardiovascular Imaging 2:1, pages 19-44.
Crossref
Crossref
J.A. Cowgill & J.N. WightJr.Jr.. 2018. Encyclopedia of Cardiovascular Research and Medicine. Encyclopedia of Cardiovascular Research and Medicine
242
256
.
J.N. WightJrJr. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Fabio Minutoli, Gianluca Di Bella, Giuseppe Vita, Riccardo Laudicella, Jan Bogaert & Sergio Baldari. (2017) Non-invasive cardiac imaging in patients with systemic amyloidosis: a practical approach with emphasis on clinical contribution of bone-seeking radiotracers. Clinical and Translational Imaging 5:6, pages 545-559.
Crossref
Crossref
Gilbert Habib, Chiara Bucciarelli-Ducci, Alida L P Caforio, Nuno Cardim, Philippe Charron, Bernard Cosyns, Aurélie Dehaene, Genevieve Derumeaux, Erwan Donal, Marc R Dweck, Thor Edvardsen, Paola Anna Erba, Laura Ernande, Oliver Gaemperli, Maurizio Galderisi, Julia Grapsa, Alexis Jacquier, Karin Klingel, Patrizio Lancellotti, Danilo Neglia, Alessia Pepe, Pasquale Perrone-Filardi, Steffen E Petersen, Sven Plein, Bogdan A Popescu, Patricia Reant, L Elif Sade, Erwan Salaun, Riemer H J A Slart, Christophe Tribouilloy, Jose Zamorano, Victoria Delgado, Kristina Haugaa & G Vijayaraghavan. (2017) Multimodality Imaging in Restrictive Cardiomyopathies: An EACVI expert consensus document In collaboration with the “Working Group on myocardial and pericardial diseases” of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography. European Heart Journal - Cardiovascular Imaging 18:10, pages 1090-1121.
Crossref
Crossref
Adam Castaño, Daniel K. Manson, Mathew S. Maurer & Sabahat Bokhari. (2017) Transthyretin Cardiac Amyloidosis in Older Adults: Optimizing Cardiac Imaging to the Corresponding Diagnostic and Management Goal. Current Cardiovascular Risk Reports 11:6.
Crossref
Crossref
Kristina Dahlem, Guido Michels, Carsten Kobe, Alexander C. Bunck, Henrik ten Freyhaus & Roman Pfister. (2017) Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging. Clinical Research in Cardiology 106:6, pages 471-473.
Crossref
Crossref
Arnault Galat, Axel Van der Gucht, Aziz Guellich, Diane Bodez, Anne-Ségolène Cottereau, Soulef Guendouz, Luc Hittinger, Jean-Luc Dubois-Randé, Violaine Plante-Bordeneuve, Emmanuel Itti, Michel Meignan, Thibaud Damy & Jean Rosso. (2017) Early Phase 99 Tc-HMDP Scintigraphy for the Diagnosis and Typing of Cardiac Amyloidosis. JACC: Cardiovascular Imaging 10:5, pages 601-603.
Crossref
Crossref
Lotte Hahn Enevoldsen, James Heaf, Liselotte Højgaard, Bo Zerahn & Philip Hasbak. (2017) Increased technetium-99 m hydroxy diphosphonate soft tissue uptake on bone scintigraphy in chronic kidney disease patients with secondary hyperparathyroidism: correlation with hyperphosphataemia. Clinical Physiology and Functional Imaging 37:2, pages 131-136.
Crossref
Crossref
Natalie J. Galant, Per Westermark, Jeffrey N. HigakiAvijit Chakrabartty. (2017) Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy. Clinical Science 131:5, pages 395-409.
Crossref
Crossref
Malte Kircher & Constantin Lapa. (2017) Novel Noninvasive Nuclear Medicine Imaging Techniques for Cardiac Inflammation. Current Cardiovascular Imaging Reports 10:2.
Crossref
Crossref
Sumeet Pawar, Muhammad Haq, Frederick L. Ruberg & Edward J. Miller. (2017) Imaging Options in Cardiac Amyloidosis: Differentiating AL from ATTR. Current Cardiovascular Imaging Reports 10:1.
Crossref
Crossref
Won Woo Lee. (2016) Recent Advances in Nuclear Cardiology. Nuclear Medicine and Molecular Imaging 50:3, pages 196-206.
Crossref
Crossref
Youssef Bennani Smires, Gérard Victor, David Ribes, Matthieu Berry, Thomas Cognet, Simon Méjean, Antoine Huart, Murielle Roussel, Antoine Petermann, Jérôme Roncalli, Didier Carrié, Hervé Rousseau, Isabelle Berry, Dominique Chauveau, Michel Galinier & Olivier Lairez. (2016) Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy. The International Journal of Cardiovascular Imaging 32:9, pages 1403-1413.
Crossref
Crossref
Axel Van Der Gucht, Arnault Galat, Jean Rosso, Aziz Guellich, J?r?me Garot, Diane Bodez, Violaine Plante-Bordeneuve, Luc Hittinger, Jean-Luc Dubois-Rand?Eva Evangelista, Myriam Sasanelli, Julia Chalaye, Michel Meignan, Emmanuel Itti & Thibaud Damy. (2015) [18F]-NaF PET/CT imaging in cardiac amyloidosis. Journal of Nuclear Cardiology 23:4, pages 846-849.
Crossref
Crossref
Stephen J. Kennel, Alan Stuckey, Helen P. McWilliams-Koeppen, Tina Richey & Jonathan S. Wall. (2015) Tc-99m Radiolabeled Peptide p5 + 14 is an Effective Probe for SPECT Imaging of Systemic Amyloidosis. Molecular Imaging and Biology 18:4, pages 483-489.
Crossref
Crossref
Arnt V. Kristen, Eva Brokbals, Fabian aus dem Siepen, Ralf Bauer, Selina Hein, Matthias Aurich, Johannes Riffel, Hans-Michael Behrens, Sandra Krüger, Peter Schirmacher, Hugo A. Katus & Christoph Röcken. (2016) Cardiac Amyloid Load. Journal of the American College of Cardiology 68:1, pages 13-24.
Crossref
Crossref
Mathew S. Maurer, Mazen Hanna, Martha Grogan, Angela Dispenzieri, Ronald Witteles, Brian Drachman, Daniel P. Judge, Daniel J. Lenihan, Stephen S. Gottlieb, Sanjiv J. Shah, D. Eric Steidley, Hector Ventura, Srinivas Murali, Marc A. Silver, Daniel Jacoby, Savitri Fedson, Scott L. Hummel, Arnt V. Kristen, Thibaud Damy, Violaine Planté-Bordeneuve, Teresa Coelho, Rajiv Mundayat, Ole B. Suhr, Márcia Waddington Cruz & Claudio Rapezzi. (2016) Genotype and Phenotype of Transthyretin Cardiac Amyloidosis. Journal of the American College of Cardiology 68:2, pages 161-172.
Crossref
Crossref
Julian D. GillmoreMathew S. MaurerRodney H. FalkGiampaolo MerliniThibaud DamyAngela DispenzieriAshutosh D. WechalekarJohn L. BerkCandida C. QuartaMartha GroganHelen J. LachmannSabahat BokhariAdam CastanoSharmila DorbalaGeoff B. JohnsonAndor W.J.M. GlaudemansTamer RezkMarianna FontanaGiovanni PalladiniPaolo MilaniPierluigi L. GuidalottiKatarina FlatmanThirusha LaneFrederick W. VonbergCarol J. WhelanJames C. MoonFrederick L. RubergEdward J. MillerDavid F. HuttBouke P. HazenbergClaudio RapezziPhilip N. Hawkins. (2016) Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation 133:24, pages 2404-2412.
Crossref
Crossref
Keyur B. ShahAnit K. MankadAdam CastanoOlakunle O. AkinboboyePhillip B. DuncanIcilma V. FergusMathew S. Maurer. (2016) Transthyretin Cardiac Amyloidosis in Black Americans. Circulation: Heart Failure 9:6.
Crossref
Crossref
Tore Bach-Gansmo, Tale N. Wien, Ayca L?ndalen & Erling Halvorsen. (2016) Myocardial uptake of bone scintigraphic agents associated with increased pulmonary uptake. Clinical Physiology and Functional Imaging 36:3, pages 237-241.
Crossref
Crossref
Emily B. Martin, Angela Williams, Tina Richey, Alan Stuckey, R. Eric Heidel, Stephen J. Kennel & Jonathan S. Wall. (2016) Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis. Scientific Reports 6:1.
Crossref
Crossref
Julien Ternacle, Diane Bodez, Aziz Guellich, Etienne Audureau, Stephane Rappeneau, Pascal Lim, Costin Radu, Soulef Guendouz, Jean-Paul Couetil, Nicole Benhaiem, Luc Hittinger, Jean-Luc Dubois-Randé, Violaine Plante-Bordeneuve, Dania Mohty, Jean-François Deux & Thibaud Damy. (2016) Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis. JACC: Cardiovascular Imaging 9:2, pages 126-138.
Crossref
Crossref
Morie A. Gertz, Merrill D. Benson, Peter J. Dyck, Martha Grogan, Terresa Coelho, Marcia Cruz, John L. Berk, Violaine Plante-Bordeneuve, Hartmut H.J. Schmidt & Giampaolo Merlini. (2015) Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis. Journal of the American College of Cardiology 66:21, pages 2451-2466.
Crossref
Crossref
Mathew S. Maurer. (2015) Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology. The American Journal of Medicine 128:12, pages 1275-1280.
Crossref
Crossref
Maarten P. van den BergRiemer H.J.A. SlartHans BlokzijlBouke P.C. Hazenberg. (2015) Transthyretin-Derived (ATTR) Amyloidotic Cardiomyopathy After Receiving a Domino Liver Allograft. Circulation 132:18.
Crossref
Crossref
Adam Casta?o, Sabahat Bokhari & Mathew S. Maurer. (2015) Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction. European Heart Journal 36:38, pages 2595-2597.
Crossref
Crossref
Joo Hee Lee, Ga Yeon Lee, Seok Jin Kim, Ki Hyun Kim, Eun-Seok Jeon, Kyung-Han Lee, Byung-Tae Kim & Joon Young Choi. (2015) Imaging Findings and Literature Review of 18F-FDG PET/CT in Primary Systemic AL Amyloidosis. Nuclear Medicine and Molecular Imaging 49:3, pages 182-190.
Crossref
Crossref
Arnault Galat, Axel Van Der Gucht, Magali Colombat, David Attias, Emmanuel Itti, Michel Meignan, Fabien Lebras, Val?rie Molinier-Frenkel, Nicole Benhaiem, Aziz Guellich, Jean Rosso & Thibaud Damy. (2015) 99mTc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosis. Journal of Nuclear Cardiology 22:4, pages 853-857.
Crossref
Crossref
Jonathan Wall, Emily Martin, Tina Richey, Alan Stuckey, Sallie Macy, Craig Wooliver, Angela Williams, James Foster, Penney McWilliams-Koeppen, Ed Uberbacher, Xiaolin Cheng & Stephen Kennel. (2015) Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis. Molecules 20:5, pages 7657-7682.
Crossref
Crossref
Yang Lu, John V. Groth & Rajyasree Emmadi. (2014) Cardiac Amyloidosis Detected on Tc-99m Bone Scan. Nuclear Medicine and Molecular Imaging 49:1, pages 78-80.
Crossref
Crossref
Walter Noordzij, Andor W. J. M. Glaudemans, Simone Longhi, Riemer H. J. A. Slart, Massimiliano Lorenzini, Bouke P. C. Hazenberg & Claudio Rapezzi. (2014) Nuclear imaging for cardiac amyloidosis. Heart Failure Reviews 20:2, pages 145-154.
Crossref
Crossref
Gianluca Di Bella, Fausto Pizzino, Fabio Minutoli, Concetta Zito, Rocco Donato, Giuseppe Dattilo, Giuseppe Oreto, Sergio Baldari, Giuseppe Vita, Bijoy K. Khandheria & Scipione Carerj. (2014) The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease. European Heart Journal - Cardiovascular Imaging 15:12, pages 1307-1315.
Crossref
Crossref
Jean Rosso, Arnaut Gallat, Aziz Guellich & Thibaud Damy. (2014) R?ponse ? la lettre de Mme Aur?lie Daumas au sujet de notre article ??Amylose syst?mique s?nile?: d?finition, diagnostic, pourquoi y penser????. La Presse M?dicale 43:9, pages 1027-1028.
Crossref
Crossref